LPL Financial’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-30,003
| Closed | -$2.79M | – | 4476 |
|
|
2021
Q4 | $2.79M | Buy |
+30,003
| New | +$1.98M | ﹤0.01% | 1846 |
|
|
2021
Q3 | – | Sell |
-2,991
| Closed | -$204K | – | 4471 |
|
|
2021
Q2 | $204K | Buy |
+2,991
| New | +$195K | ﹤0.01% | 3893 |
|
|
2021
Q1 | – | Sell |
-6,417
| Closed | -$493K | – | 4179 |
|
|
2020
Q4 | $493K | Buy |
6,417
+589
| +10% | +$44.1K | ﹤0.01% | 2777 |
|
|
2020
Q3 | $436K | Sell |
5,828
-50
| -0.9% | -$3.33K | ﹤0.01% | 2586 |
|
|
2020
Q2 | $370K | Sell |
5,878
-479
| -8% | -$26.4K | ﹤0.01% | 2671 |
|
|
2020
Q1 | $267K | Buy |
6,357
+151
| +2% | +$6.92K | ﹤0.01% | 2588 |
|
|
2019
Q4 | $282K | Buy |
6,206
+140
| +2% | +$6.62K | ﹤0.01% | 2829 |
|
|
2019
Q3 | $278K | Buy |
6,066
+985
| +19% | +$55.4K | ﹤0.01% | 2742 |
|
|
2019
Q2 | $298K | Sell |
5,081
-204
| -4% | -$10.5K | ﹤0.01% | 2705 |
|
|
2019
Q1 | $237K | Buy |
+5,285
| New | +$242K | ﹤0.01% | 2827 |
|
|
2018
Q4 | – | Sell |
-4,685
| Closed | -$216K | – | 3300 |
|
|
2018
Q3 | $216K | Buy |
4,685
+5
| +0.1% | +$203 | ﹤0.01% | 2945 |
|
|
2018
Q2 | $204K | Buy |
+4,680
| New | +$201K | ﹤0.01% | 2971 |
|
|
2017
Q2 | – | Sell |
-1,170
| Closed | -$17K | – | 3005 |
|
|
2017
Q1 | $17K | Sell |
1,170
-30
| -3% | -$444 | ﹤0.01% | 2685 |
|
|
2016
Q4 | $18K | Hold |
1,200
| – | – | ﹤0.01% | 2663 |
|
|
2016
Q3 | $22K | Sell |
1,200
-455
| -27% | -$7.55K | ﹤0.01% | 2607 |
|
|
2016
Q2 | $27K | Sell |
1,655
-5,115
| -76% | -$91.4K | ﹤0.01% | 2581 |
|
|
2016
Q1 | $131K | Buy |
6,770
+500
| +8% | +$8.01K | ﹤0.01% | 2900 |
|
|
2015
Q4 | $117K | Buy |
6,270
+2,215
| +55% | +$45.2K | ﹤0.01% | 2961 |
|
|
2015
Q3 | $87K | Sell |
4,055
-1,515
| -27% | -$51.4K | ﹤0.01% | 2669 |
|
|
2015
Q2 | $252K | Sell |
5,570
-375
| -6% | -$16.3K | ﹤0.01% | 2445 |
|
|
2015
Q1 | $256K | Sell |
5,945
-308
| -5% | -$14.3K | ﹤0.01% | 2371 |
|
|
2014
Q4 | $217K | Sell |
6,253
-1,815
| -22% | -$73.7K | ﹤0.01% | 2443 |
|
|
2014
Q3 | $330K | Buy |
8,068
+218
| +3% | +$9.73K | ﹤0.01% | 2096 |
|
|
2014
Q2 | $460K | Sell |
7,850
-745
| -9% | -$46.9K | ﹤0.01% | 1862 |
|
|
2014
Q1 | $541K | Buy |
8,595
+203
| +2% | +$13.5K | ﹤0.01% | 1678 |
|
|
2013
Q4 | $491K | Sell |
8,392
-3,878
| -32% | -$203K | ﹤0.01% | 1739 |
|
|
2013
Q3 | $533K | Buy |
12,270
+875
| +8% | +$58.8K | ﹤0.01% | 1607 |
|
|
2013
Q2 | $877K | Buy |
+11,395
| New | +$930K | 0.01% | 1210 |
|
LPL Financial's ARNA Position: Q1 2022 in Review
LPL Financial sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 30,003 shares — an estimated $2.79M sold.
LPL Financial first reported a position in ARNA in Q2 2013 and held it in 28 quarters. The position peaked at $2.79M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- LPL Financial reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- LPL Financial sold 30,003 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.79M.
- LPL Financial first reported a position in Arena Pharmaceuticals Inc in Q2 2013 and held it in 28 quarters.
- LPL Financial's Arena Pharmaceuticals Inc position peaked at $2.79M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on LPL Financial's 13F filing for Q1 2022, filed 16 May 2022.